Literature DB >> 24900848

C-ring cannabinoid lactones: a novel cannabinergic chemotype.

Rishi Sharma1, Spyros P Nikas1, Jason Jianxin Guo1, Srikrishnan Mallipeddi1, JodiAnne T Wood1, Alexandros Makriyannis1.   

Abstract

As a part of our controlled-deactivation ligand development project, we recently disclosed a series of (-)-Δ(8)-tetrahydrocannabinols (THCs) with a metabolically labile ester group at the 2'-position of the side chain. Now, we have replaced the C-ring in the classical THC structure with a hydrolyzable seven-membered lactone. One of the synthesized analogues binds with high affinity to the CB1 receptor (K i = 4.6 nM) and exhibits much lower affinities for the mCB2 and the hCB2. Also, in vitro functional characterization found the compound to be an agonist at rCB1. Consistent with our rational design, the lead cannabinergic lactone identified here is susceptible to metabolic inactivation by plasma esterases, while the respective acid metabolite is inactive at CB receptors. These results are highlighted with molecular modeling of the two regiosomeric lactones.

Entities:  

Keywords:  Baeyer−Villiger rearrangement; Cannabinoids; lactones

Year:  2014        PMID: 24900848      PMCID: PMC4027620          DOI: 10.1021/ml4005304

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  30 in total

Review 1.  Soft drug design: general principles and recent applications.

Authors:  N Bodor; P Buchwald
Journal:  Med Res Rev       Date:  2000-01       Impact factor: 12.944

Review 2.  A historical overview of chemical research on cannabinoids.

Authors:  R Mechoulam; L Hanus
Journal:  Chem Phys Lipids       Date:  2000-11       Impact factor: 3.329

Review 3.  CB1 cannabinoid receptor ligands.

Authors:  Ganesh A Thakur; Spyros P Nikas; Alexandros Makriyannis
Journal:  Mini Rev Med Chem       Date:  2005-07       Impact factor: 3.862

Review 4.  Pharmacology of cannabinoid CB1 and CB2 receptors.

Authors:  R G Pertwee
Journal:  Pharmacol Ther       Date:  1997       Impact factor: 12.310

Review 5.  Cannabinoid receptors and pain.

Authors:  R G Pertwee
Journal:  Prog Neurobiol       Date:  2001-04       Impact factor: 11.685

6.  Molecular cloning, expression and function of the murine CB2 peripheral cannabinoid receptor.

Authors:  D Shire; B Calandra; M Rinaldi-Carmona; D Oustric; B Pessègue; O Bonnin-Cabanne; G Le Fur; D Caput; P Ferrara
Journal:  Biochim Biophys Acta       Date:  1996-06-07

Review 7.  The role of the endocannabinoid system in eating disorders: pharmacological implications.

Authors:  Eva M Marco; Silvana Y Romero-Zerbo; María-Paz Viveros; Francisco J Bermudez-Silva
Journal:  Behav Pharmacol       Date:  2012-09       Impact factor: 2.293

8.  Molecular characterization of a peripheral receptor for cannabinoids.

Authors:  S Munro; K L Thomas; M Abu-Shaar
Journal:  Nature       Date:  1993-09-02       Impact factor: 49.962

9.  Synthesis, anti-inflammatory, and antioxidant activities of 18beta-glycyrrhetinic acid derivatives as chemical mediators and xanthine oxidase inhibitors.

Authors:  Dravidum Maitraie; Chi-Feng Hung; Huang-Yao Tu; Ya-Ting Liou; Bai-Luh Wei; Shyh-Chyun Yang; Jih-Pyang Wang; Chun-Nan Lin
Journal:  Bioorg Med Chem       Date:  2009-02-21       Impact factor: 3.641

10.  Metabolically labile cannabinoid esters: a 'soft drug' approach for the development of cannabinoid-based therapeutic drugs.

Authors:  F Minutolo; M G Cascio; I Carboni; T Bisogno; G Prota; S Bertini; M Digiacomo; M Bifulco; V Di Marzo; M Macchia
Journal:  Bioorg Med Chem Lett       Date:  2007-06-20       Impact factor: 2.823

View more
  6 in total

1.  2012 Division of medicinal chemistry award address. Trekking the cannabinoid road: a personal perspective.

Authors:  Alexandros Makriyannis
Journal:  J Med Chem       Date:  2014-05-01       Impact factor: 7.446

Review 2.  Rearrangements of organic peroxides and related processes.

Authors:  Ivan A Yaremenko; Vera A Vil'; Dmitry V Demchuk; Alexander O Terent'ev
Journal:  Beilstein J Org Chem       Date:  2016-08-03       Impact factor: 2.883

3.  Novel C-Ring-Hydroxy-Substituted Controlled Deactivation Cannabinergic Analogues.

Authors:  Shashank Kulkarni; Spyros P Nikas; Rishi Sharma; Shan Jiang; Carol A Paronis; Michael Z Leonard; Bin Zhang; Chandrashekhar Honrao; Srikrishnan Mallipeddi; Jimit Girish Raghav; Othman Benchama; Torbjörn U C Järbe; Jack Bergman; Alexandros Makriyannis
Journal:  J Med Chem       Date:  2016-07-13       Impact factor: 7.446

4.  Probing the carboxyester side chain in controlled deactivation (-)-δ(8)-tetrahydrocannabinols.

Authors:  Spyros P Nikas; Rishi Sharma; Carol A Paronis; Shashank Kulkarni; Ganesh A Thakur; Dow Hurst; JodiAnne T Wood; Roger S Gifford; Girija Rajarshi; Yingpeng Liu; Jimit Girish Raghav; Jason Jianxin Guo; Torbjörn U C Järbe; Patricia H Reggio; Jack Bergman; Alexandros Makriyannis
Journal:  J Med Chem       Date:  2014-12-16       Impact factor: 7.446

5.  Controlled-Deactivation CB1 Receptor Ligands as a Novel Strategy to Lower Intraocular Pressure.

Authors:  Sally Miller; Shashank Kulkarni; Alex Ciesielski; Spyros P Nikas; Ken Mackie; Alexandros Makriyannis; Alex Straiker
Journal:  Pharmaceuticals (Basel)       Date:  2018-05-22

Review 6.  Cyclobutanes in Small-Molecule Drug Candidates.

Authors:  Marnix R van der Kolk; Mathilde A C H Janssen; Floris P J T Rutjes; Daniel Blanco-Ania
Journal:  ChemMedChem       Date:  2022-03-29       Impact factor: 3.540

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.